Golde W T, Robinson-Dunn B, Stobierski M G, Dykhuizen D, Wang I N, Carlson V, Stiefel H, Shiflett S, Campbell G L
State University of New York at Stony Brook, 11794-8161, USA.
J Clin Microbiol. 1998 Apr;36(4):1015-9. doi: 10.1128/JCM.36.4.1015-1019.1998.
In recent years, the utility of serum-based diagnostic testing for Lyme disease has improved substantially; however, recovery by culture of the bacterium from skin biopsies of suspected patients is still the only definitive laboratory test. Reinfection of patients has been assumed to occur but as yet has not been documented by serial isolates from the same person. We present a case of culture-confirmed reinfection of a patient in Menominee County, Michigan. Borrelia burgdorferi was isolated from the skin punch biopsy specimens during each episode of erythema migrans (EM) and was subjected to molecular strain typing, genetic analysis of two outer surface protein genes, protein profile analysis, and serum antibody response testing. Results show that these isolates are distinct strains of the bacterium and that the two episodes of EM were caused by independent infections. This report describes the documented, culture-confirmed reinfection of a human by two different strains of B. burgdorferi.
近年来,基于血清的莱姆病诊断检测效用有了显著提高;然而,从疑似患者的皮肤活检样本中培养出该细菌仍然是唯一确定的实验室检测方法。虽然假定患者会再次感染,但目前尚未通过同一个人的系列分离株得到证实。我们报告了密歇根州梅诺米尼县一名患者经培养确诊再次感染的病例。在每次游走性红斑(EM)发作期间,从皮肤打孔活检标本中分离出伯氏疏螺旋体,并对其进行分子菌株分型、两个外膜蛋白基因的遗传分析、蛋白谱分析以及血清抗体反应检测。结果表明,这些分离株是该细菌的不同菌株,且两次EM发作是由独立感染引起的。本报告描述了由两种不同的伯氏疏螺旋体菌株对一名人类进行的有记录、经培养确诊的再次感染。